logo-loader
viewTrainline

Trainline could make stock market debut as soon as next month, according to report

According to The Times, the company is finalising plans for a stock market debut that is expected to value it at about £1bn

train
Trainline's former owner Exponent tried to float the business in 2014 but sold it to KKR instead

Rail and bus ticket website Trainline is reportedly set to launch the largest listing of a UK-based company this year.

According to The Times, the company is finalising plans for a stock market debut and could go public as soon as next month.

READ: Trainline's float hits the buffers as KKR moves in

The initial public offering is expected to value Trainline at about £1bn, the newspaper reported.

Trainline was founded in 1997 by Virgin Trains and was sold to Exponent Private Equity in 2006.

Exponent tried to float Trainline in 2014 but sold it to US private equity firm KKR a year later for £450mln, instead.

Trainline processes more than £3bn of ticket sales a year in 45 countries. It employs about 600 people in London, Edinburgh and Paris.

The company is one of the UK’s so-called unicorns – a privately owned, tech start ups valued at more than US$1bn.

In the year to the end of February 2018, Trainline generated revenues of £167mln and a pre-tax profit of £38mln.

 

Quick facts: Trainline

Price: 442 GBX

LSE:TRN
Market: LSE
Market Cap: £2.1 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Dyadic touts recent collaborations, 3Q highlights at Jefferies London...

Dyadic International Inc (NASDAQ:DYAI) CEO Mark Emalfarb and CCO Matthew Jones tell Proactive's Andrew Scott the duo are in London for the Jefferies London Healthcare Conference, the biotech's third year attending.  Emalfarb and Jones say the Florida-based biotech is touting its recent...

14 hours, 16 minutes ago

RNS

Holding(s) in Company

3 days, 20 hours ago

Trainline

6 days, 14 hours ago

Announcement on Board of Directors

6 days, 22 hours ago

Holding(s) in Company

1 week, 6 days ago

2 min read